|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.801
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.721
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.559
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.546
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.543
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.531
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.481
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.437
|
|
|
|
angiotensin activated signaling pathway
|
GO:0038166 |
4 |
0.434
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.420
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.411
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.386
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.385
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.373
|
Mouse |
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.371
|
Mouse |
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.371
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.369
|
Mouse Worm |
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.350
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.346
|
|
|
|
regulation of lung blood pressure
|
GO:0014916 |
2 |
0.336
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.276
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.267
|
|
|
|
positive regulation of monooxygenase activity
|
GO:0032770 |
2 |
0.261
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.256
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.254
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.252
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.244
|
|
|
|
vasodilation by angiotensin involved in regulation of systemic arterial blood pressure
|
GO:0002033 |
2 |
0.242
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.238
|
Mouse |
|
|
fused antrum stage
|
GO:0048165 |
1 |
0.234
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.230
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.229
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.222
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.222
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.219
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.219
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.211
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.208
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.208
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.208
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.200
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.199
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.198
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.193
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.187
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.184
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.183
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.181
|
Mouse |
|
|
regulation of tolerance induction to self antigen
|
GO:0002649 |
1 |
0.178
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.174
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.171
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.167
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.167
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.166
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.164
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.160
|
Mouse |
|
|
g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger
|
GO:0007199 |
1 |
0.155
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.153
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.151
|
|
|
|
negative regulation of blood circulation
|
GO:1903523 |
15 |
0.148
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.141
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.140
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.140
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.139
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.132
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.130
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.130
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.129
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.127
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.124
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.124
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.122
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.122
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.122
|
Mouse |
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.121
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.117
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.117
|
Mouse |
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.117
|
|
|
|
mesoderm structural organization
|
GO:0048338 |
1 |
0.117
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.117
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.117
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.115
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.115
|
Mouse |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.115
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902219 |
1 |
0.114
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.113
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.112
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.112
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.109
|
|
|
|
neural plate mediolateral regionalization
|
GO:0021998 |
1 |
0.108
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.106
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.106
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.105
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.105
|
Mouse |
|
|
cholesterol import
|
GO:0070508 |
2 |
0.104
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.103
|
Mouse Worm |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.103
|
Mouse |
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.102
|
|
|
|
negative regulation of vasoconstriction
|
GO:0045906 |
2 |
0.100
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.100
|
|
|
|
b cell tolerance induction
|
GO:0002514 |
2 |
0.100
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.099
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.099
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.096
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.095
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.095
|
|
|
|
negative regulation of heart contraction
|
GO:0045822 |
11 |
0.095
|
|
|
|
positive regulation of tolerance induction to self antigen
|
GO:0002651 |
1 |
0.095
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.095
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.095
|
Mouse |
|
|
phospholipid catabolic process
|
GO:0009395 |
5 |
0.094
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.094
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.094
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.093
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.093
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.091
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.090
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.090
|
|
|
|
lens fiber cell apoptotic process
|
GO:1990086 |
4 |
0.088
|
|
|
|
cellular zinc ion homeostasis
|
GO:0006882 |
9 |
0.088
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.088
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.088
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.087
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.086
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.086
|
|
|
|
positive regulation of t cell tolerance induction
|
GO:0002666 |
6 |
0.085
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.085
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.083
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.081
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.081
|
|
|
|
regulation of anti mullerian hormone signaling pathway
|
GO:1902612 |
1 |
0.081
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.080
|
|
|
|
cellular response to osmotic stress
|
GO:0071470 |
7 |
0.080
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.079
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.079
|
|
|
|
bronchus morphogenesis
|
GO:0060434 |
2 |
0.079
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.079
|
|
|
|
regulation of response to osmotic stress
|
GO:0047484 |
3 |
0.077
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
6 |
0.077
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.076
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.075
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.074
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.073
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.072
|
|
|
|
common partner smad protein phosphorylation
|
GO:0007182 |
2 |
0.072
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.070
|
Mouse |
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.070
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.070
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.070
|
|
|
|
response to cell cycle checkpoint signaling
|
GO:0072396 |
1 |
0.069
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.069
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.069
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.069
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.068
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.066
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.066
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.066
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.064
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.063
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.063
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.063
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.062
|
|
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.062
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.062
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.061
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.061
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.060
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.060
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.060
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.060
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.059
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.058
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.057
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.057
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.056
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.056
|
|
|
|
negative regulation of anti mullerian hormone signaling pathway
|
GO:1902613 |
1 |
0.056
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.056
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.055
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.055
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.054
|
Mouse |
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.053
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.053
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.053
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.053
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.053
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.052
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.052
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.052
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.051
|
|
|
|
positive regulation of filopodium assembly
|
GO:0051491 |
10 |
0.051
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.051
|
|
|
|
growth plate cartilage chondrocyte development
|
GO:0003431 |
3 |
0.051
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.051
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.050
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.049
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.049
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.049
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
0.048
|
|
|
|
anti mullerian hormone signaling pathway
|
GO:1990262 |
1 |
0.048
|
|
|
|
indolalkylamine metabolic process
|
GO:0006586 |
4 |
0.047
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.047
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.046
|
|
|
|
regulation of b cell tolerance induction
|
GO:0002661 |
2 |
0.046
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.046
|
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
7 |
0.045
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.045
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.044
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.044
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.043
|
|
|
|
positive regulation of interferon gamma secretion
|
GO:1902715 |
3 |
0.043
|
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.043
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.043
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.043
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.043
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.043
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.043
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.042
|
|
|
|
ovarian cumulus expansion
|
GO:0001550 |
1 |
0.042
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.041
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.041
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.041
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.041
|
Mouse |
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.041
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.041
|
|
|
|
mullerian duct regression
|
GO:0001880 |
1 |
0.041
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.041
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.040
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.040
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.040
|
Mouse |
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.040
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.040
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.040
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.039
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.039
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.039
|
Mouse |
|
|
superoxide anion generation
|
GO:0042554 |
11 |
0.039
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.039
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.039
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.039
|
|
|
|
negative regulation of cardiac muscle tissue growth
|
GO:0055022 |
7 |
0.039
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.039
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.038
|
|
|
|
copper ion transmembrane transport
|
GO:0035434 |
5 |
0.038
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.038
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.038
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.038
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.038
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.037
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.037
|
|
|
|
positive regulation of triglyceride biosynthetic process
|
GO:0010867 |
6 |
0.037
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.037
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.036
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.036
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.036
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.036
|
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.036
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.036
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.036
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.036
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.036
|
|
|
|
growth plate cartilage chondrocyte growth
|
GO:0003430 |
2 |
0.036
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.035
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.035
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.035
|
|
|
|
positive regulation of tolerance induction
|
GO:0002645 |
8 |
0.035
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.035
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.035
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.035
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.035
|
|
|
|
negative regulation of neurotrophin trk receptor signaling pathway
|
GO:0051387 |
2 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.034
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.034
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.034
|
|
|
|
membrane protein proteolysis
|
GO:0033619 |
10 |
0.034
|
|
|
|
negative regulation of peptide secretion
|
GO:0002792 |
16 |
0.034
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.033
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.033
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.033
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.033
|
|
|
|
venous blood vessel development
|
GO:0060841 |
13 |
0.032
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.032
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.032
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.032
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.032
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.032
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.032
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.031
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.031
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.031
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.031
|
|
|
|
sterol import
|
GO:0035376 |
2 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.031
|
|
|
|
response to dietary excess
|
GO:0002021 |
18 |
0.031
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.031
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.031
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.031
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.031
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.030
|
|
|
|
lateral mesoderm formation
|
GO:0048370 |
3 |
0.030
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.030
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.030
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.030
|
Mouse |
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.030
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.030
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.030
|
Mouse |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.030
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.030
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.029
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.029
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.029
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.029
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.029
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.029
|
|
|
|
negative regulation of metalloenzyme activity
|
GO:0048553 |
2 |
0.029
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.028
|
|
|
|
regulation of filopodium assembly
|
GO:0051489 |
13 |
0.028
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.028
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.028
|
Mouse |
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.028
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.027
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.027
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.027
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.027
|
Mouse |
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.027
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.027
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.027
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.027
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.027
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.027
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.027
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.027
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.026
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.026
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.026
|
|
|
|
response to ketone
|
GO:1901654 |
15 |
0.026
|
|
|
|
glycerophospholipid catabolic process
|
GO:0046475 |
5 |
0.026
|
|
|
|
negative regulation of endothelial cell differentiation
|
GO:0045602 |
2 |
0.026
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.026
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.026
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.026
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.025
|
|
|
|
stress response to metal ion
|
GO:0097501 |
3 |
0.025
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.025
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.025
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.025
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.025
|
|
|
|
reelin mediated signaling pathway
|
GO:0038026 |
3 |
0.025
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.025
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.025
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.025
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.025
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.025
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.025
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.025
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.025
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.025
|
|
|
|
positive regulation of axon guidance
|
GO:1902669 |
5 |
0.024
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.024
|
|
|
|
t cell tolerance induction
|
GO:0002517 |
6 |
0.024
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.024
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.024
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.024
|
Mouse |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.024
|
|
|
|
oogenesis stage
|
GO:0022605 |
3 |
0.024
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.024
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.024
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.024
|
|
|
|
lateral mesodermal cell fate specification
|
GO:0048377 |
2 |
0.023
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.023
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.023
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.023
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.023
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.023
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.023
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.023
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.023
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.023
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.023
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.023
|
|
|
|
layer formation in cerebral cortex
|
GO:0021819 |
13 |
0.022
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.022
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.022
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.022
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.022
|
|
|
|
neurotrophin trk receptor signaling pathway
|
GO:0048011 |
8 |
0.022
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.022
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.022
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.022
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.022
|
|
|
|
cgmp biosynthetic process
|
GO:0006182 |
13 |
0.022
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.021
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.021
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.021
|
|
|
|
phosphatidylcholine metabolic process
|
GO:0046470 |
13 |
0.021
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.021
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.021
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.021
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.021
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
lateral mesoderm morphogenesis
|
GO:0048369 |
3 |
0.021
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.021
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
|
filopodium assembly
|
GO:0046847 |
19 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.020
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.020
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.020
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.020
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.020
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.020
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.020
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.020
|
|
|
|
nucleotide sugar metabolic process
|
GO:0009225 |
4 |
0.020
|
|
|
|
positive regulation of phosphoprotein phosphatase activity
|
GO:0032516 |
1 |
0.020
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.020
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.020
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.020
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.019
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.019
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.019
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.019
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.019
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
Mouse |
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.019
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.019
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.019
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.019
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.019
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.019
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.019
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.019
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.019
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.018
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.018
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.018
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.018
|
|
|
|
smooth muscle cell apoptotic process
|
GO:0034390 |
5 |
0.018
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.018
|
|
|
|
response to glucagon
|
GO:0033762 |
3 |
0.018
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.018
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.018
|
|
|
|
positive regulation of dendritic spine development
|
GO:0060999 |
12 |
0.018
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.018
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.018
|
|
|
|
regulation of dendritic spine development
|
GO:0060998 |
22 |
0.018
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.018
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.018
|
Mouse |
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.018
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.018
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.018
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.018
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.018
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.018
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.017
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.017
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.017
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.017
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.017
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.017
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.017
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.017
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.017
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.017
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.017
|
|
|
|
lateral mesodermal cell fate commitment
|
GO:0048372 |
2 |
0.017
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.017
|
|